Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113735778B reveals efficient Ag2O promoted route. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing globally.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN109851599B details a novel one-pot synthesis of 2-aminobenzofurans using TIPS-EBX. This method offers high yields and simplified purification for pharmaceutical intermediates.
Patent CN101407459B details a novel synthesis of monohydroxy-2-acylphenylacetates. This route offers scalable production for antitumor drug leads with optimized cost efficiency.
Patent CN110467579B reveals a metal-free, iodine-promoted route for 5-trifluoromethyl-1,2,4-triazoles. Discover cost-effective API intermediate manufacturing solutions.
Patent CN113735778A reveals a silver-promoted cyclization route for high-purity imidazoles, offering cost-effective scalable manufacturing solutions.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering safer CO surrogates and improved supply chain reliability for API manufacturing.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Patent CN113121462B reveals a metal-free synthesis of 5-trifluoromethyl-1,2,3-triazoles. Discover cost-effective, scalable manufacturing for high-purity pharmaceutical intermediates.
Patent CN115093355B reveals a novel transesterification method for pyrrole esters. This report analyzes cost reduction in fine chemical manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN110862368A reveals a metal-free photocatalytic route for benzocoumarins using DDQ/TBN and oxygen, offering significant cost and purity advantages for pharmaceutical intermediates.
Patent CN111808040B reveals a green aqueous synthesis for 2-oxo-oxazolidine-4-carboxylic acids, offering high yields and cost reduction in API manufacturing.
Novel metal-free synthesis of pyrimidoindazoles via one-pot cascade. High yields, mild conditions, ideal for API intermediates and kinase inhibitor development.
Patent CN117720537B reveals a novel indole-furan catalyst enabling high-purity asymmetric synthesis with significant cost reduction in fine chemical manufacturing and supply chain reliability.
Patent CN102718659B enables high-yield synthesis of 4-bromo-2-nitrophenylacetic acid. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Advanced synthesis of chiral spiro bisphosphine ligands via Pd-catalyzed coupling. Delivers high-purity intermediates for asymmetric catalysis with scalable manufacturing.
Patent CN116041345B reveals copper-catalyzed synthesis of hydantoin skeletons. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107501153A reveals a novel two-step synthesis for trifluoroethyl aziridines. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN111690947B reveals a metal-free electrochemical synthesis for trifluoromethylated arylamides, offering significant cost reduction in API manufacturing and greener processing.
Novel Pd-catalyzed carbonylation using benzyl formate for high-purity aryl acetamides. Reduces oxidant use and simplifies supply chains for pharma intermediates.